Boosted by its Genzyme division, is confident Medivation shareholders will back its proposed takeover of the U.S. cancer drug company, Sanofi, reported higher quarterly profit on Friday. Setting up what could be a lengthy battle with a $9.3 billion offer to buy Medivation after it...